Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography

European Journal of Radiology

Volumn 53, Issue 2, 2005, Pages 206-212

  Tiling, Reinhold ^a   Keßler, Mareike ^a   Untch, Michael ^a   Sommer, Harald ^a   Linke, Rainer ^a   Hahn, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; MRI; Scintimammography; Tc 99m sestamibi

Indexed keywords

BIOLOGICAL ORGANS; DIAGNOSIS; HISTOLOGY; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; OPTICAL CORRELATION; PATHOLOGY; PATIENT TREATMENT;

BENIGN MAMMOGRAPHY; BREAST CANCER; HISTOPATHOLOGY; SESTAMIBI SCINTIMAMMOGRAPHY (SMM);

TUMORS;

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TRACER;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; TUMOR VOLUME;

BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 12444317700     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2004.02.006     Document Type: Article

References (30)

1. Kopans D.B. The positive predictive value of mammography. Am. J. Roentgenol. 158:1992;521-526
2. Harms S.E., Flamig D.P., Evans W.P., Harries S.A., Bown S. MR imaging of the breast: current status and future potential. Am. J. Roentgenol. 163:1994;1039-1047
3. Heywang-Köbrunner S.H. Contrast-enhanced magnetic resonance imaging of the breast. Invest. Radiol. 29:1994;94-104
4. Orel S.G., Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 220:2001;13-30
5. Liberman L., Morris E., Lee M., et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR. 179:2002;171-178
6. Khalkhali I., Mena I., Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using Technetium-99m sestamibi. Eur. J. Nucl. Med. 21:1994;357-362
7. Taillefer R., Robidoux A., Lambert R., Turpin S., Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J. Nucl. Med. 36:1995;1758-1765
8. Khalkhali I., Cutrone J., Mena I., et al. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology. 196:1995;421-426
9. Tiling R., Khalkhali I., Sommer H., et al. Role of Technetium-99m sestamibi scintimammography and contrast enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms. Eur. J. Nucl. Med. 24:1997;1221-1229
10. Palmedo H., Biersack H.J., Lastoria S., et al. Scintimammography with Technetium-99m methoxyisobutylisonitrile: results of a prospective European multicenter trial. Eur. J. Nucl. Med. 25:1998;375-385
11. Tiling R., Khalkhali I., Sommer H. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography. Nucl. Med. Commun. 19:1998;55-62
12. Khalkhali I., Villanueva-Meyer J., Edell S.L., et al. Diagnostic accuracy of Tc-99m sestamibi breast imaging: multicenter trial results. J. Nucl. Med. 41:2000;1973-1979
13. Tiling R., Kessler M., Untch M. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography. Onkologie. 26(1):2003;27-31
14. Tiling R., Linke R., Kessler M., et al. Breast scintigraphy using Tc-99m sestamibi-use and limitations. Nuklearmedizin. 41(3):2002;148-156
15. Carvalho P.A., Chiu M.L., Kronaug J.F., et al. Subcellular distribution and analysis of Tc-99m-MIBI in isolated perfused rat hearts. J. Nucl. Med. 33:1992;1516-1521
16. Maublant J.C., Zheng Z., Rapp M., et al. In vitro uptake of Tc-99m texoboroxime in carcinoma cell lines and normal cell lines: comparison with Tc-99m sestamibi and Thallium-201. J. Nucl. Med. 34:1993;1949-1952
17. Khalkhali I., Baum J.K., Villanueva-Meyer J., et al. 99m-Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. Radiology. 222:2002;149-155
18. Heywang-Kobrunner S.H., Bick U., Bradley W.G., et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur. Radiol. 11(4):2001;531-546
19. Kuhl C.K., Schild H.H. Dynamic image interpretation of MRI of the breast. J. Magn. Reson. Imaging. 12(6):2000;965-974
20. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions. Radiology. 211:1999;101-110
21. Bagni B., Franceschetto A., Casolo A., et al. Scintimammography with Tc-99m-MIBI and magnetic resonance imaging in the evaluation of breast cancer. Eur. J. Nucl. Med. Mol. Imaging. 30:2003;1383-1388
22. Imbriaco M., Del Vecchio S., Riccardi A., et al. Scintimammography with Tc-99m-MIBI versus dynamic MRI for non-invasive characterization of breast masses. Eur. J. Nucl. Med. 28:2001;56-63
23. Maini C.L., Tofani A., Sciuto R., et al. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma. J. Nucl. Med. 38:1997;1546-1551
24. Mankoff D.A., Dunnwald L.K., Gralow J.R., Ellis G.K., Drucker M.J., Livingston R.B. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using Technetium-99m-sestamibi scintimammography. Cancer. 85:1999;2410-2423
25. Sciuto R., Pasqualoni R., Bergomi S., et al. Prognostic value of Tc-99m-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy. J. Nucl. Med. 43:2002;745-751
26. Vinnicombe S.J., MacVicar A.D., Guy R.L., et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology. 198:1996;333-340
27. Knopp M.V., Brix G., Junkermann H.J., Sinn H.P. MR mammography with pharmakokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. MRI Clin. North Am. 2:1994;633-658
28. Rieber A., Zeitler H., Rosenthal H., et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br. J. Radiol. 70:1997;452-458
29. Scopinaro F., Pani R., De Vincentis G., Soluri A., Pellegrini R., Porfiri L.M. High-resolution scintimammography improves the accuracy of Technetium-99m methoxy-isobutylisonitrile scintimammography: use of a new dedicated gamma camera. Eur. J. Nucl. Med. 26:1999;1279-1288
30. Brem R.F., Schoonjans J.M., Kieper D.A., Majewski S., Goodman S., Civelek C. High-resolution scintimammography: a pilot study. J. Nucl. Med. 43:2002;909-915